Kerala Ayurveda reports 20.7% YTD revenue growth to Rs 108.7 crore, with EBITDA positive. Promoter plans Rs 20 crore debt-to-equity conversion at Rs 327.99 per share and to acquire the remaining 26% in AHWCPL via preferential issue, subject to approvals.